Share This Article:

Chronic Administration of the Resveratrol or N-PEP-12 Ameliorates the Endothelial Dysfunction in Aging Rats

Full-Text HTML XML Download Download as PDF (Size:274KB) PP. 69-74
DOI: 10.4236/pp.2014.51011    3,740 Downloads   5,523 Views   Citations


Here we investigated the effects of chronic treated with resveratrol, a polyphenol (3,4,5-trihydroxystilbene) found in more than 70 plant species and food products such as red grapes, berries and peanuts, or N-PEP-12, a mix of peptides, on arteries in aging rats. Aging rats have shown endothelial dysfunction. Aged Sprague-Dawley rats (18 months old) were treated with resveratrol (20 mg/kg/day by gavage) or N-PEP-12 (60 mg/kg/day by gavage) for 10 weeks. 24 hours after the last administration of resveratrol or N-PEP-12, the animals were weighed and diastolic and systolic blood pressure was measured by tail-cuff plethysmography. Thoracic and abdominal aorta artery segments were obtained from resveratrol-, N-PEP-12-and vehicle-treated rats and were mounted in isometric tension for isolated vessels. We found that resveratrol and N-PEP-12 improved acetylcholine-induced relaxation in the old animals. These results suggest that chronic administration of resveratrol or N-PEP-12 may in part reduce endothelial dysfunction in the aging.

Cite this paper

G. Flores, J. Hernández-Cabrera, C. Santamaria-Juarez, R. Vázquez-Roque, E. Monserrat-Hernández, M. Gómez-Villalobos, J. Flores-Hernández, F. Atonal-Flores and J. López-López, "Chronic Administration of the Resveratrol or N-PEP-12 Ameliorates the Endothelial Dysfunction in Aging Rats," Pharmacology & Pharmacy, Vol. 5 No. 1, 2014, pp. 69-74. doi: 10.4236/pp.2014.51011.


[1] M. Yadav, S. Jain, A. Bhardwaj, R. Nagpal, M. Puniya, R. Tomar, V. Singh, O. Parkash, G. B. Prasad, F. Marotta and H. Yadav, “Biological and Medicinal Properties of Grapes and Their Bioactive Constituents: An Update,” Journal of Medicinal Food, Vol. 12, No. 3, 2009, pp. 473-484.
[2] Z. Ungvari, G. Kaley, R. de Cabo, W. E. Sonntag and A. Csiszar, “Mechanisms of Vascular Aging: New Perspectives,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol. 65, No. 10, 2010, pp. 1028-1041.
[3] A. Csiszar, Z. Ungvari, J. G. Edwards, P. Kaminski, M. S. Wolin, A. Koller and G. Kaley, “Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function,” Circulation Research, Vol. 90, No. 11, 2002, pp. 1159-1166.
[4] A. Csiszar, N. Labinskyy, Z. Orosz, Z. Xiangmin, R. Buffenstein and Z. Ungvari, “Vascular Aging in the LongestLiving Rodent, the Naked Mole-Rat,” American Journal of Physiology, Vol. 293, No. 2, 2007, pp. H919-H927.
[5] A. J. Donato, I. Eskurza, A. E. Silver, A. S. Levy, G. L. Pierce, P. E. Gates and D. R. Seals, “Direct Evidence of Endothelial Oxidative Stress with Aging in Humans: Relation to Impaired Endothelium Dependent Dilation and Upregulation of Nuclear Factor-KappaB,” Circulation Research, Vol. 100, No. 1, 2007, pp. 1659-1666.
[6] M. Frombaum, S. Le Clanche, D. Bonnefont-Rousselot and D. Borderie, “Antioxidant Effects of Resveratrol and Other Stilbene Derivatives on Oxidative Stress and NO Bioavailability: Potential Benefits to Cardiovascular Diseases,” Biochimie, Vol. 94, No. 2, 2012, pp. 269-276.
[7] X. A. Alvarez, L. Corzo, M. Laredo, C. Sampedro, R. Cacabelos, M. Windisch, H. Moessler and T. H. Crook, “Neuropeptide Dietary Supplement N-PEP-12 Enhances Cognitive Function and Activates Brain Bioelectrical Activity in Healthy Elderly Subjects,” Methods and Findings in Experimental and Clinical Pharmacology, Vol. 27, No. 7, 2005, pp. 483-487.
[8] T. H. Crook, S. H. Ferris, X. A. Alvarez, M. Laredo and H. Moessler, “Effects of N-PEP-12 on Memory among Older Adults,” International Clinical Psychopharmacology, Vol. 20, No. 2, 2005, pp. 97-100.
[9] D. Volc, A. Alvarez and H. Moessler, “Cognitive Effects of the Novel Neuroprotective Dietary Supplement N-PEP-12: Evidences from a Self-Assessment Study,” Jatros, Neurologie and Psychiatrie, 2005, pp. 1-7.
[10] F. Sanchez, M. de J. Gomez-Villalobos, I. Juárez, L. Quevedo and G. Flores, “Dendritic Morphology on Neurons from Prefrontal Cortex, Hippocampus and Nucleus Accumbens in Altered in Adult Spontaneously Hypertensive Rats,” Synapse, Vol. 65, No. 3, 2011, pp. 198-206.
[11] J. G. Lopez-Lopez, J. Moral-Sanz, G. Frazziano, M. J. Gomez-Villalobos, L. Moreno, C. Menendez, J. FloresHernandez, J. A. Lorente, A. Cogolludo and F. PerezVizcaino, “Type 1 Diabetes-Induced Hyper-Responsiveness to 5-Hydroxytryptamine in Rat Pulmonary Arteries via Oxidative Stress and Induction of Cyclooxygenase-2,” Journal of Pharmacology and Experimental Therapeutics, Vol. 338, No. 1, 2011, pp. 400-407.
[12] A. G. Rajapakse, G. Yepuri, J. M. Carvas, S. Stein, C. M. Matter, I. Scerri, J. Ruffieux, J. P. Montani, X. F. Ming and Z. Yang, “Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol,” PLoS One, Vol. 6, No. 4, 2011, e19237.
[13] E. V. Serkina, O. A. Gromova, I. Iu. Torshin, N. Iu. Sotnikova and A. A. Nikonov, “Cerebrolysin Alleviates Perinatal CNS Disorders through the Autoimmune Modulation and Antioxidant Protection,” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, Vol. 108, No. 11, 2008, pp. 62-66.
[14] J. Behbahani, S. J. Thandapilly, X. L. Louis, Y. Huang, Z. Shao, M. A. Kopilas, P. Wojciechowski, T. Netticadan and H. D. Anderson, “Resveratrol and Small Artery Compliance and Remodeling in the Spontaneously Hypertensive Rat,” American Journal of Hypertension, Vol. 23, No. 12, 2010, pp. 1273-1278.
[15] A. M. El-Mowafy, M. Alkhalaf and N. N. Nassar, “Resveratrol Reverses ET-1-Evoked Mitogenic Effects in Human Coronary Arterial Cells by Activating the KinaseG to Inhibit ERK-Enzymes,” International Journal of Cardiology, Vol. 136, No. 3, 2009, pp. 263-269.
[16] H. J. Ma, Y. K. Cao, Y. X. Liu, R. Wang and Y. M. Wu, “Microinjection of Resveratrol into Rostral Ventrolateral Medulla Decreases Sympathetic Vasomotor Tone through Nitric Oxide and Intracellular Ca2+ in Anesthetized Male Rats,” Acta Pharmacologica Sinica, Vol. 29, No. 6, 2008, pp. 906-912.
[17] M. Subramanian, P. Balasubramanian, H. Garver, C. Northcott, H. Zhao, J. R. Haywood, G. D. Fink, S. M. Mohan Kumar and P. S. Mohan Kumar, “Chronic Estradiol-17β Exposure Increases Superoxide Production in the Rostral Ventrolateral Medulla and Causes Hypertension: Reversal by Resveratrol,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, Vol. 300, No. 6, 2011, pp. R1560-1568.
[18] N. Toda and T. Okamura, “Modulation of Renal Blood Flow and Vascular Tone by Neuronal Nitric Oxide Synthase-Derived Nitric Oxide,” Journal of Vascular Research, Vol. 48, No. 1, 2011, pp. 1-10.
[19] P. A. Kroon, A. Iyer, P. Chunduri, V. Chan and L. Brown, “The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential,” Current Medicinal Chemistry, Vol. 17, No. 23, 2010, pp. 2442-2355.
[20] J. W. Rush, J. Quadrilatero, A. S. Levy and R. J. Ford, “Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats,” Experimental Biology and Medicine (Maywood), Vol. 232, No. 6, 2007, pp. 814-822.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.